Symrise (SY1) Given a €58.00 Price Target by Sanford C. Bernstein Analysts
Symrise (FRA:SY1) received a €58.00 ($71.60) price objective from analysts at Sanford C. Bernstein in a report issued on Wednesday. The firm presently has a “neutral” rating on the stock. Sanford C. Bernstein’s price target indicates a potential downside of 6.45% from the stock’s current price.
Several other equities analysts have also commented on SY1. Kepler Capital Markets set a €65.50 ($80.86) target price on Symrise and gave the company a “neutral” rating in a research note on Wednesday. JPMorgan Chase & Co. set a €65.00 ($80.25) target price on Symrise and gave the company a “neutral” rating in a research note on Wednesday. Goldman Sachs Group set a €55.60 ($68.64) target price on Symrise and gave the company a “sell” rating in a research note on Wednesday. Commerzbank set a €64.00 ($79.01) price target on Symrise and gave the company a “neutral” rating in a research report on Wednesday. Finally, Barclays set a €65.00 ($80.25) price target on Symrise and gave the company a “neutral” rating in a research report on Wednesday, February 28th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of €68.42 ($84.47).
Symrise (SY1) traded down €4.54 ($5.60) during trading on Wednesday, reaching €62.00 ($76.54). The company had a trading volume of 1,598 shares. The firm has a market capitalization of $7,910.00 and a price-to-earnings ratio of 30.85. Symrise has a 52-week low of €56.96 ($70.32) and a 52-week high of €73.48 ($90.72).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.